Document is current
Any future updates will be listed below
-
Authors
,
Mason, Mike J. https://orcid.org/0000-0002-5652-7739
Schinke, Carolina
Eng, Christine L. P.
Towfic, Fadi
Gruber, Fred
Dervan, Andrew https://orcid.org/0000-0002-6482-8654
White, Brian S. https://orcid.org/0000-0002-2954-4410
Pratapa, Aditya https://orcid.org/0000-0002-3323-6250
Guan, Yuanfang
Chen, Hongjie
Cui, Yi
Li, Bailiang
Yu, Thomas
Chaibub Neto, Elias
Mavrommatis, Konstantinos
Ortiz, Maria
Lyzogubov, Valeriy
Bisht, Kamlesh
Dai, Hongyue Y.
Schmitz, Frank
Flynt, Erin
Dan Rozelle,
Danziger, Samuel A. https://orcid.org/0000-0002-5669-414X
Ratushny, Alexander
Dalton, William S.
Goldschmidt, Hartmut
Avet-Loiseau, Herve
Samur, Mehmet
Hayete, Boris
Sonneveld, Pieter
Shain, Kenneth H.
Munshi, Nikhil
Auclair, Daniel
Hose, Dirk
Morgan, Gareth
Trotter, Matthew
Bassett, Douglas
Goke, Jonathan https://orcid.org/0000-0002-0825-4991
Walker, Brian A. https://orcid.org/0000-0002-8615-6254
Thakurta, Anjan
Guinney, Justin https://orcid.org/0000-0003-1477-1888
- License Information
-
More Information
Article History
Received: 10 October 2019
Revised: 14 January 2020
Accepted: 3 February 2020
First Online: 14 February 2020
Compliance with ethical standards
:
: Please note the following byline authors: FT, KM, KB, FS, EF, AR, SAD, AD, DB, MT, AT have employment and/or equity ownership in Celgene. AD also had equity in Twinstrand Biosciences. WSD has employment with M2Gen. HG has research support (Amgen, BMS, Celgene, Chugai, Janssen, Molecular Partners, MSD, Sanofi, Mundipharma, Takeda and Novartis), advisory boards (Adaptive Biotechnology, Amgen, BMS, Celgene, Janssen, Sanofi and Takeda), honoraria (ArtTempi, BMS, Celgene, Chugai, Janssen, Novartis and Sanofi). NM has consulted for Abbvie, Adaptive, Amgen, Celgene, Janssen, Takeda and Oncopep and also has equity in Oncopep. KHS is on advisory boards for: Celgene, BMS, Amgen, Takeda, Janssen and Sanofi Genzyme, has received research funding from AbbVie, and has consulted for Adaptive Biotechnologies.
